UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.526-526

2023

Volltextzugriff (PDF)

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2023-03, Vol.22 (2), p.300-311

2023

Volltextzugriff (PDF)

Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3597-3597

2022

Volltextzugriff (PDF)

Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RAS MULTI (ON) inhibitor

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.591-591

2022

Volltextzugriff (PDF)

Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

Clinical nutrition ESPEN, 2021-02, Vol.41, p.293-298

2021

Volltextzugriff (PDF)

Dietary management and major clinical events in patients with longchain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

Clinical nutrition ESPEN, 2020-12, Vol.41, p.293-298

2020

Volltextzugriff (PDF)

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.16-17

2020

Volltextzugriff (PDF)

AML-058: First-In-Human Study of a Trail Receptor Agonist Fusion Protein, Eftozanermin Alfa, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Diffuse Large B-Cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S177-S177

2020

Volltextzugriff (PDF)

A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer

Frontiers in oncology, 2020-04, Vol.10, p.457-457

2020

Volltextzugriff (PDF)

Healthcare costs among patients with hemophilia A treated with factor replacement or bypassing agents

Current medical research and opinion, 2019-08, Vol.35 (8), p.1433-1440

2019

Volltextzugriff (PDF)

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Blood, 2017-12, Vol.130 (Suppl_1), p.89-89

2017

Volltextzugriff (PDF)

Abstract TP72: The PRISMS Trial: Baseline Characteristics of the First 100 Subjects

Stroke (1970), 2016-02, Vol.47 (suppl_1)

2016

Volltextzugriff (PDF)

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis

Journal of managed care & specialty pharmacy, 2015-12, Vol.21 (12), p.1106

2015

Volltextzugriff (PDF)

Prototype Sodium‐Ion Batteries Using an Air‐Stable and Co/Ni‐Free O3‐Layered Metal Oxide Cathode

Advanced materials (Weinheim), 2015-11, Vol.27 (43), p.6928-6933

2015

Volltextzugriff (PDF)

Fe‐Based Tunnel‐Type Na 0.61 [Mn 0.27 Fe 0.34 Ti 0.39 ]O 2 Designed by a New Strategy as a Cathode Material for Sodium‐Ion Batteries

Advanced energy materials, 2015-11, Vol.5 (22)

2015

Volltextzugriff (PDF)

Prototype Sodium-Ion Batteries Using an Air-Stable and Co/Ni-Free O3-Layered Metal Oxide Cathode

Advanced materials (Weinheim), 2015-11, Vol.27 (43), p.6928-6933

2015

Volltextzugriff (PDF)

Fe-Based Tunnel-Type Na0.61[Mn0.27Fe0.34Ti0.39]O2 Designed by a New Strategy as a Cathode Material for Sodium-Ion Batteries

Advanced energy materials, 2015-11, Vol.5 (22), p.n/a

2015

Volltextzugriff (PDF)

Fe-Based Tunnel-Type Na sub(0.61)[Mn sub(0.27)Fe sub(0.34)Ti sub(0.39)]O sub(2) Designed by a New Strategy as a Cathode Material for Sodium-Ion Batteries

Advanced energy materials, 2015-11, Vol.5 (22), p.np-np

2015

Volltextzugriff (PDF)

Air-Stable Copper-Based P2-Na 7/9 Cu 2/9 Fe 1/9 Mn 2/3 O 2 as a New Positive Electrode Material for Sodium-Ion Batteries

Advanced science, 2015-06, Vol.2 (6), p.1500031

2015

Volltextzugriff (PDF)

Air‐Stable Copper‐Based P2‐Na7/9Cu2/9Fe1/9Mn2/3O2 as a New Positive Electrode Material for Sodium‐Ion Batteries

Advanced science, 2015-06, Vol.2 (6), p.1500031-n/a

2015

Volltextzugriff (PDF)

Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies

Contemporary clinical trials, 2015-03, Vol.41, p.211-218

2015

Volltextzugriff (PDF)

TRENDS IN CONVENTIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS AMONG U.S. ADULTS WITH TYPE II DIABETES OR PRE-DIABETES: THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 1999-2010

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1491-E1491

2013

Volltextzugriff (PDF)

High-level expression of the Penicillium notatum glucose oxidase gene in Pichia pastoris using codon optimization

Biotechnology letters, 2012-03, Vol.34 (3), p.507-514

2012

Volltextzugriff (PDF)

A DYNAMIC QUANTILE REGRESSION TRANSFORMATION MODEL FOR LONGITUDINAL DATA

Statistica Sinica, 2009-07, Vol.19 (3), p.1137-1153

2009

Volltextzugriff (PDF)

Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer

Clinical lung cancer, 2008-09, Vol.9 (5), p.306-306

2008

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)
Dissertationen
(1)

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials

Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor

Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RAS MULTI (ON) inhibitor

Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

Dietary management and major clinical events in patients with longchain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

AML-058: First-In-Human Study of a Trail Receptor Agonist Fusion Protein, Eftozanermin Alfa, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Diffuse Large B-Cell Lymphoma

A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer

Healthcare costs among patients with hemophilia A treated with factor replacement or bypassing agents

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Abstract TP72: The PRISMS Trial: Baseline Characteristics of the First 100 Subjects

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis

Prototype Sodium‐Ion Batteries Using an Air‐Stable and Co/Ni‐Free O3‐Layered Metal Oxide Cathode

Fe‐Based Tunnel‐Type Na 0.61 [Mn 0.27 Fe 0.34 Ti 0.39 ]O 2 Designed by a New Strategy as a Cathode Material for Sodium‐Ion Batteries

Prototype Sodium-Ion Batteries Using an Air-Stable and Co/Ni-Free O3-Layered Metal Oxide Cathode

Fe-Based Tunnel-Type Na0.61[Mn0.27Fe0.34Ti0.39]O2 Designed by a New Strategy as a Cathode Material for Sodium-Ion Batteries

Fe-Based Tunnel-Type Na sub(0.61)[Mn sub(0.27)Fe sub(0.34)Ti sub(0.39)]O sub(2) Designed by a New Strategy as a Cathode Material for Sodium-Ion Batteries

Air-Stable Copper-Based P2-Na 7/9 Cu 2/9 Fe 1/9 Mn 2/3 O 2 as a New Positive Electrode Material for Sodium-Ion Batteries

Air‐Stable Copper‐Based P2‐Na7/9Cu2/9Fe1/9Mn2/3O2 as a New Positive Electrode Material for Sodium‐Ion Batteries

Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies

TRENDS IN CONVENTIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS AMONG U.S. ADULTS WITH TYPE II DIABETES OR PRE-DIABETES: THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 1999-2010

High-level expression of the Penicillium notatum glucose oxidase gene in Pichia pastoris using codon optimization

A DYNAMIC QUANTILE REGRESSION TRANSFORMATION MODEL FOR LONGITUDINAL DATA

Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer

Suchergebnisse filtern